Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -

[1] Siegel RL(2019)Cancer statistics, 2019 CA Cancer J Clin 69 7-34

[2] Miller KD(2018)Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018 Eur J Cancer 103 356-387

[3] Jemal A(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent Eur Urol 71 618-629

[4] Ferlay J(2008)The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis Clin Radiol 63 387-395

[5] Colombet M(2014)Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis Skelet Radiol 43 1503-1513

[6] Soerjomataram I(2006)Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer Eur Urol 50 1006-1013

[7] Dyba T(1997)Prostate-specific membrane antigen expression in normal and malignant human tissues Clin Cancer Res 3 81-85

[8] Randi G(2007)Prostate-specific membrane antigen expression as a predictor of prostate cancer progression Hum Pathol 38 696-701

[9] Bettio M(2013)Prognostic Gleason grade grouping: data based on the modified Gleason scoring system BJU Int 111 753-760

[10] Mottet N(2015)Initial evaluation of [(18)F]DCFPyL for prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer Mol Imaging Biol 17 565-574

[1] Siegel RL(2019)Cancer statistics, 2019 CA Cancer J Clin 69 7-34

[2] Miller KD(2018)Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018 Eur J Cancer 103 356-387

[3] Jemal A(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent Eur Urol 71 618-629

[4] Ferlay J(2008)The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis Clin Radiol 63 387-395

[5] Colombet M(2014)Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis Skelet Radiol 43 1503-1513

[6] Soerjomataram I(2006)Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer Eur Urol 50 1006-1013

[7] Dyba T(1997)Prostate-specific membrane antigen expression in normal and malignant human tissues Clin Cancer Res 3 81-85

[8] Randi G(2007)Prostate-specific membrane antigen expression as a predictor of prostate cancer progression Hum Pathol 38 696-701

[9] Bettio M(2013)Prognostic Gleason grade grouping: data based on the modified Gleason scoring system BJU Int 111 753-760

[10] Mottet N(2015)Initial evaluation of [(18)F]DCFPyL for prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer Mol Imaging Biol 17 565-574